Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Zhejiang University Cancer Center, Hangzhou 310058, China.
Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
Crit Rev Oncol Hematol. 2021 Apr;160:103227. doi: 10.1016/j.critrevonc.2021.103227. Epub 2021 Mar 3.
Liver transplantation (LT) is the most effective treatment for end-stage liver diseases. The immunometabolism microenvironment undergoes massive changes at the interface of immune functionalities and metabolic regulations after LT. These changes considerably modify post-transplant complications, and immune cells play an influential role in the hepatic immunometabolism microenvironment after LT. Therefore, adequate studies on the complex pathobiology of immune cells are critical to prevent post-transplant complications, and the interplay between cellular metabolism and immune function is evident. Furthermore, immune cells perform their specified functions, such as activation or differentiation, accompanied by alterations in metabolic pathways, such as metabolic reprogramming. This transformation remarkably affects post-transplant complications like rejection. By targeting different metabolic pathways, regulations of metabolism are employed to shape immune responses. These differences of metabolic pathways allow for selective regulation of immune responses to further develop effective therapies that prevent graft loss after LT. This review examines immune cells in the hepatic immunometabolism microenvironment after LT, summarizes possible mechanisms and potential prevention on rejection to acquire immune tolerance, and offers some insight into references for scientific research along with clinical treatment.
肝移植(LT)是治疗终末期肝病最有效的方法。LT 后,免疫代谢微环境在免疫功能和代谢调节的界面上发生了巨大变化。这些变化极大地改变了移植后的并发症,免疫细胞在 LT 后的肝免疫代谢微环境中发挥着重要作用。因此,充分研究免疫细胞的复杂病理生物学对于预防移植后并发症至关重要,细胞代谢和免疫功能之间的相互作用是显而易见的。此外,免疫细胞在执行特定功能(如激活或分化)时伴随着代谢途径的改变,如代谢重编程。这种转变显著影响排斥等移植后并发症。通过靶向不同的代谢途径,可以调节代谢来塑造免疫反应。这些代谢途径的差异允许对免疫反应进行选择性调节,以进一步开发有效的治疗方法,防止 LT 后移植物丢失。本综述探讨了 LT 后肝免疫代谢微环境中的免疫细胞,总结了获得免疫耐受的可能机制和潜在预防排斥反应的措施,并为科学研究和临床治疗提供了一些参考。